Recordati announced approval of an eye drop treatment to reduce corneal crystals. “We are pleased to bring Cystadrops® to...
Read moreBy Cystinosis Research Network
August 25, 2020
We are going virtual! The CRN is introducing a series of virtual meetups taking place this fall. Available to...
Read moreBy Cystinosis Research Network
August 7, 2020
Partnering with RDMD, this program aims to accelerate cystinosis research to ultimately improve treatment options. We welcome you to...
Read moreBy Cystinosis Research Network
July 9, 2020
News from Leadiant regarding new storage of Cystaran (cysteamine ophthalmic solution) 0.44%. Beginning December 22, 2025, shipments of Cystaran...
Read moreThe next phase of clinical development for the CF10 prodrug to treat cystinosis has been announced. The Cystinosis Foundation...
Read moreThe Neuromuscular Clinic at Massachusetts General Hospital (MGH) led by Dr. Reza Seyedsadjadi, is currently enrolling participants for a...
Read moreEmory University in Atlanta, Georgia, is actively recruiting for the Cohort 0 control groupin the CYStem clinical trial. While...
Read moreA new chapter in cystinosis research has begun. Novartis has officially opened the next phase of its CYStem Phase...
Read moreFor our families using Cystadrops, we received the following information from Recordati. This update was in response to direct...
Read more